1

“From microscope to management”

Dr Mark Newbold

CEO, Heart of England NHS FT

web: www.marknewbold.co.uktwitter: @drmarknewbold

today...

my journey into management

CEO perspective on pathology and future

questions / discussion

my journey - training

1983 - graduated from Birmingham Uni

1984 - house jobs - Dudley Rd Hosp & QEH

1985 - SHO pathology - General & Childrens

1986 - Reg in Histopathology - Warwick Hosp

1986-91 - Lecturer in Pathology, Med Sch

1991 - Consultant at Warwick Hospital

1989 MRCPath 1991 MD

my journey - post-training

1991 - 1999 Consultant at Warwick HospitalHead of Cytology / Postgraduate Clinical Tutor / Clinical Director of Pathology

ISM Mgt training / Dip. BA at Warwick Business School

1999 - 2007 Consultant at Walsgrave / UHCWClinical Director of Pathology / Head of Division / Associate Medical Director

Managing Director, Rugby St Cross Hospital

Led Cov & Warks Acute Services Review for SHA

Aspiring CEO programme, West MIdlands SHA

2007 - left clinical work for CEO post

Board post

some reflections...

build skills base in your own specialty

moving outside pathology is a key step

take lots of advice - mentor / coach / or just ask!

delegate - encourage, support, don’t always do!

there is no ‘black book’

it’s all about people

don’t try to conform to management stereotype - understand what is needed and deliver it your way

The real challenges!

persisting health inequalities

care quality - especially elderly care

variable / poor clinical outcomes

money - (£20bn) Nicholson challenge

outmoded approach to chronic illness

politics, esp. around ‘local’ services

key issues for provider CEO?

clinical outcomes

patient satisfaction

targets - performance and quality

financial balance

governors / local issues

QIPP / £20bn challenge

shift from hospital to community / home care

what would CEOs like from you?

guidance and advice

clear clinical planning / strategy

creation of clinical consensus

constructive involvement in ‘real world’ debate on resource / constraints

leadership on outcomes and quality

future of pathology…

Nicholson challenge / economic outlook

Future of smaller hospitals / specialist services

Carter report - £500m efficiencies via rationalising?

GP direct access c50% work for most labs, with significant surplus – ie it subsidises hospital lab service

No real issues re quality / service standards

predictions...

• Split of hospital and GP/direct access pathology

• Some reconfiguration of hospital services as result

• Centralised processing for Cellular Path?

• What about the consultants??

• Specialist clinical services

• Telepathology

• Where / How will bright young people like yourselves want to work?